Clinical Trial Update: TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients [Phase 2]

View source ↗

Summary

Phase 2 exploratory study assessing pharmacokinetics, safety and anti-HIV activity of etravirine given with boosted atazanavir and one NRTI in treatment-experie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Intelence (Etravirine)
• Norvir (ritonavir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Janssen R&D Ireland | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-09-30